HTFL
Ticker
Heartflow, Inc.
HTFL · Healthcare · HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the Uni…Heartflow, Inc. (HTFL), in the Healthcare sector, has 31 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 1 purchase and 30 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Oct 22 and filed Oct 26. The most active filer was John C.M. Farquhar with 14 filings. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
31
1 buy · 30 sells
Traders, ttm
7
7 insiders
Volume, ttmiDollar value disclosed in the window
$142.3M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Oct 22
Filed Oct 26
ADViAverage daily dollar volume
$75.9M
market data
Share price · 12M
$59.05 (+74.5%)
Adjusted for splits and dividends.
Volume by month
Buys $1.1M
Sells $141.3M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
JFRecent filings
Campbell RogersSALE
Chief Medical Officer
$1.3M23,933 sh × $55.01
Exec Oct 22
Filed Oct 26 · 6:00 PM ET John C.M. FarquharSALE Chief Executive Officer $1.9M
38,900 sh × $49.57
Exec Oct 12
Filed Oct 14 · 6:05 PM ET Campbell RogersSALE Chief Medical Officer $987K
19,682 sh × $50.15
Exec Sep 18
Filed Sep 21 · 6:19 PM ET Vikram VergheseSALE Chief Financial Officer $1.2M
24,345 sh across 2 lots
Exec Sep 17
Filed Sep 18 · 8:46 PM ET Vikram VergheseSALE Chief Financial Officer $1.7M
34,307 sh across 2 lots
Exec Sep 11
Filed Sep 15 · 7:44 PM ET John C.M. FarquharSALE Chief Executive Officer $1.8M
38,900 sh across 2 lots
Exec Sep 10
Filed Sep 14 · 6:41 PM ET Vikram VergheseSALE Chief Financial Officer $332K
6,640 sh × $50.03
Exec Sep 8
Filed Sep 10 · 5:24 PM ET Vikram VergheseSALE Chief Financial Officer $1.7M
33,416 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 5:29 PM ET John C.M. FarquharSALE Chief Executive Officer $1.4M
27,230 sh × $50.00
Exec Aug 21
Filed Aug 25 · 5:32 PM ET John C.M. FarquharSALE Chief Executive Officer $1.5M
32,676 sh × $45.00
Exec Aug 18
Filed Aug 20 · 5:56 PM ET Campbell RogersSALE Chief Medical Officer $380K
9,219 sh × $41.23
Exec Aug 17
Filed Aug 19 · 9:04 PM ET John C.M. FarquharSALE Chief Executive Officer $608K
15,560 sh × $39.06
Exec Aug 14
Filed Aug 18 · 6:38 PM ET John C.M. FarquharSALE Chief Executive Officer $639K
22,562 sh × $28.31
Exec Aug 10
Filed Aug 12 · 5:07 PM ET Campbell RogersSALE Chief Medical Officer $237K
9,219 sh × $25.72
Exec Jul 15
Filed Jul 17 · 5:54 PM ET John C.M. FarquharSALE Chief Executive Officer $626K
22,562 sh × $27.75
Exec Jul 10
Filed Jul 13 · 8:25 PM ET John C.M. FarquharSALE Chief Executive Officer $1.4M
38,900 sh × $35.00
Exec Jun 24
Filed Jun 26 · 5:30 PM ET John C.M. FarquharSALE Chief Executive Officer $643K
22,562 sh × $28.50
Exec Jun 10
Filed Jun 12 · 5:30 PM ET Campbell RogersSALE Chief Medical Officer $261K
9,219 sh × $28.34
Exec May 18
Filed May 20 · 5:30 PM ET John C.M. FarquharSALE Chief Executive Officer $657K
22,562 sh × $29.12
Exec May 11
Filed May 13 · 5:30 PM ET Bain Capital Life Sciences III General Partner, LLCSALE 10% owner $58.9M
2,000,000 sh across 4 lots
Exec Apr 28
Filed Apr 30 · 5:30 PM ET John C.M. FarquharSALE Chief Executive Officer $603K
22,562 sh × $26.72
Exec Apr 10
Filed Apr 14 · 5:30 PM ET Campbell RogersSALE Chief Medical Officer $1.6M
64,533 sh × $24.64
Exec Apr 1
Filed Apr 3 · 5:30 PM ET Campbell RogersSALE Chief Medical Officer $1.7M
64,533 sh × $25.69
Exec Mar 19
Filed Mar 23 · 5:30 PM ET John C.M. FarquharSALE Chief Executive Officer $243K
9,725 sh × $25.00
Exec Mar 18
Filed Mar 20 · 5:30 PM ET John C.M. FarquharSALE Chief Executive Officer $291K
12,837 sh × $22.66
Exec Mar 10
Filed Mar 12 · 5:30 PM ET